New "HAS-BLED" Tool Assesses Risk for those with Atrial Fibrillation

Rate This

One of the most common questions we get centers around the use of anticoagulant drugs, either the brand drug, Coumadin, or the generic version, warfarin and whether or not an atrial fibrillation patient should be on them. Anticoagulants decrease stroke risk, but can also increase bleeding risk. How do you sort it all out? It's just as frustrating for our doctors as it is for us.

A new tool, called HAS-BLED, may help. Used in conjunction with CHADS2 scores, it can help doctors assess our risks and determine whether or not we should be on anticoagulants.

Mellanie True Hills Bio

Atrial Fibrillation: Symptoms, Causes and Risks

6 Reasons You May Be Getting Heart Palpitations

MRI May Help Determine Stroke Risk for Those With Afib Some Day

New Five Box Maze Procedure Is Promising Treatment for Persistent Atrial ...

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Mellanie True Hills Expert View Profile Send Message

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.